Rhode Island S3022 mandates insurers to create plans for nonopioid pain management coverage and restricts utilization review for nonopioid drugs.
Rhode Island S3022 requires insurers to develop plans for coverage and access to nonnarcotic, nonopioid, and nonmedication pain management for moderate to severe pain. It mandates that these plans be filed with the health insurance commissioner for approval, who will consider the adequacy of access to a broad spectrum of pain management services. The bill also restricts utilization review for nonopioid drugs, prohibiting more restrictive or extensive protocols than those applied to opioids.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.